Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2003
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195363 Reacting 2,5-disubstituted-phenylalkylsulfide compound with halogenating agent to produce 2,5-disubstituted-phenylsulfenylhalide compound
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195231 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195173 Colchinol derivatives as angiogenesis inhibitors
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/15/2003EP1352903A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
10/15/2003EP0916651B1 Phenylalkylcarboxylic acid derivatives
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003CN1449387A Improved methods of synthesis for 9-substituted hypoxanthine derivatives
10/15/2003CN1449378A Herbicidally active benzoylcyclohexanediones
10/15/2003CN1449273A Antimicotic nail varnish composition
10/15/2003CN1448791A Novel photosensitive compound, resin and composition
10/15/2003CN1124263C Stabilised monomer composition
10/14/2003US6632949 Halogenating agents
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1087945B1 Method for producing carbonyldiimidazole
10/08/2003EP1027380B1 Catalyst and method for trimerization of isocyanates
10/08/2003EP0912522B1 Polyfunctional crosslinking acylimidazolidinone derivatives
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1446805A Method for preparing 1-proparagyl hydantoin
10/08/2003CN1446804A Compound possessing fungicidal property and its usage
10/08/2003CN1446803A Chemosynthesis method of 1-chloroformyl-3-mesyl-2-imidzaolidinone
10/08/2003CN1446802A Chemosynthesis method of 1-chloroformyl-3-acetyl-2-imidazolidinone
10/08/2003CN1446801A Chemosynthesis method of 1-choroformyl-2-imidazolidinone
10/07/2003US6630593 A process for preparing a 1-substituted 5-hydroxymethylimidazole of the formula: wherein R represents alkyl, hydroxyalkyl, allyl, or substituted or unsubstituted arylmethyl or diarylmethyl, comprising the step of reacting a
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630498 Bioavailablity; using to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure
10/07/2003US6630497 For therapy of hypertension and congestive heart failure; angiotensin II antagonist
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187275 Diagnosis, therapy tumors
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187045 Central nervous system disorders; controlling lipid metabolism; respiratory system disorders
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186955 Stabilised compositions having and antibacterial activity
10/02/2003US20030186947 Such as 4-((5-cyclopropyl-methyl-amino)-8,8-dimethyl-5,6,7,8-tetrahydro-naphthalene -2yl-ethynyl)-benzoic acid for treating diseases responsive to treatment by retinoids
10/02/2003US20030186803 Imidazole carbenes
10/01/2003EP1349005A1 Photosensitive compound, resin and composition
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003CN1445021A Dibasic ion liquid containing dialkylation imidazole salt and imidazole as well as its preparing method
09/2003
09/30/2003US6627758 Ligand including (i) at least two different types of heteroatoms selected from nitrogen, phosphorus, and sulfur, and (ii) at least one of imidazole, pyrazole, and pyridine; transition metal complex for carbonylation to aldehyde
09/30/2003US6627647 Treating an inflammatory disease which comprises administering to a patient in need of such treatment a compound for autoimmune diseases
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/25/2003WO2003077913A1 Peptide deformylase inhibitors
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002102375A3 Imidazole derivatives for modulating sodium channels
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181496 Having Transforming Growth Factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
09/25/2003US20030181479 Treating ischemic arrhythmia, myocardial ischemia and infarction, asthma, rhinitis, pain, gastrointestinal disorders; a histamine H3 receptor agonistic activity
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030180236 Resorcinol derivatives
09/25/2003US20030177591 Method of dyeing keratin-containing fibers
09/25/2003CA2478331A1 Peptide deformylase inhibitors
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics